Rocket® Pleural Catheters: QOL, Feasibility and Satisfaction in Recurrent MPE Patients
Malignant Pleural Effusion
About this trial
This is an interventional treatment trial for Malignant Pleural Effusion
Eligibility Criteria
Inclusion Criteria:
- Presence of symptomatic (BDI < 6), and moderate sized (> 1/3 of hemithorax) MPE
- Persistent malignant pleural effusion that is free flowing
- Life expectancy of at least 2 months (approximate duration of follow-up for the study)
- Age greater than 18
- Consent to undergoing TPC treatment for recurrent MPE
Exclusion Criteria:
- Prior attempted chemical pleurodesis on ipsilateral side
- Active pleural or pulmonary infection
- Currently hospitalized for reasons other than MPE or in hospice care
- Life expectancy estimated at less than 2 months
- Inability to complete questionnaires (English or French)
- Refusal to give informed consent
- Pregnant women
Sites / Locations
- Ottawa Hospital, General CampusRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Rocket® IPC- Long External Length
Rocket® IPC- Short External Length
Intervention Rocket® IPC- Long External Length: a regular full length (long catheter) Rocket catheter inserted at baseline, with an external length of 16cm. Catheter length will be modified at 2 weeks in clinic, shortened to an external length of 5cm (short catheter). Patient satisfaction will be collected at 2 weeks prior to the modification, and at 4 weeks when the patient has a shorter catheter. The modification is easily done without any use of anesthesia as it is external to the patient using the tool kit that comes along with the catheter. Patients will be referred to palliative home care services for assistance with drainage. The drainage catheters to be used in this study will be samples supplied by Rocket Medical Inc., for Dr. Amjadi to evaluate their product.
Intervention Rocket® IPC- Short External Length : a regular full length (long catheter) Rocket catheter inserted at baseline, with an external length of 16cm. Catheter length will be modified at 2 weeks in clinic, shortened to an external length of 5cm (short catheter). Patient satisfaction will be collected at 2 weeks prior to the modification, and at 4 weeks when the patient has a shorter catheter. The modification is easily done without any use of anesthesia as it is external to the patient using the tool kit that comes along with the catheter. Patients will be referred to palliative home care services for assistance with drainage. The drainage catheters to be used in this study will be samples supplied by Rocket Medical Inc., for Dr. Amjadi to evaluate Rocket's product.